They demonstrated that the combination of Wogonin and radiation therapy effectively suppressed DNA methylation and histone deacetylation in radioresistant breast cancer cells, leading to epigenetic upregulation of CpG site methylation in the Keap1 promoter region. Here, KEAP1 is linked to breast carcinoma.